Connection
Ping-Ching Hsu to Hepatitis B Surface Antigens
This is a "connection" page, showing publications Ping-Ching Hsu has written about Hepatitis B Surface Antigens.
|
|
Connection Strength |
|
 |
|
 |
|
0.043 |
|
|
|
-
Yu HC, Lin KH, Hsu PI, Tsay FW, Wang HM, Tsai TJ, Lai KH. Real-world application of the roadmap model in chronic hepatitis B patients with telbivudine therapy. Clin Ther. 2013 Sep; 35(9):1386-99.
Score: 0.028
-
Chen WC, Lo GH, Lai KH, Cheng JS, Hsu PI, Lin CK. Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding. J Chin Med Assoc. 2004 Nov; 67(11):557-64.
Score: 0.015